MCW	O	O
1875011	O	O
STAT	O	O
PCXR	O	O
S/P	O	O
CT	O	O
D/C	O	O
PORTABLE	O	O
AP	O	O
CHEST	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
,	O	O
1759	O	O
HOURS	O	O
.	O	O
COMPARISON	O	O
:	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
,	O	O
0802	O	O
HOURS	O	O
.	O	O
FINDINGS	O	O
:	O	O
THE	O	O
RIGHT	O	O
CHEST	O	O
TUBE	O	O
HAS	O	O
BEEN	O	O
REMOVED	O	O
.	O	O
THE	O	O
MILD	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
THICKENING	3_Yellow_Days	3_Yellow_Days
AT	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
APEX	3_Yellow_Days	3_Yellow_Days
AND	3_Yellow_Days	3_Yellow_Days
TINY	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
LOCULATION	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
AIR	3_Yellow_Days	3_Yellow_Days
AT	3_Yellow_Days	O
THE	3_Yellow_Days	O
APEX	3_Yellow_Days	O
APPEAR	3_Yellow_Days	O
UNCHANGED	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
SLIGHT	3_Yellow_Days	1_Red_Minutes
DIFFUSE	3_Yellow_Days	1_Red_Minutes
INCREASE	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
OPACITY	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
RIGHT	3_Yellow_Days	1_Red_Minutes
LUNG	3_Yellow_Days	1_Red_Minutes
RELATIVE	3_Yellow_Days	1_Red_Minutes
TO	3_Yellow_Days	O
THE	3_Yellow_Days	O
LEFT	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
.	O	O
IN	O	3_Yellow_Days
PART	O	3_Yellow_Days
THIS	O	3_Yellow_Days
MAY	O	3_Yellow_Days
BE	O	3_Yellow_Days
DUE	O	O
TO	O	O
OVERLYING	O	3_Yellow_Days
SOFT	O	3_Yellow_Days
TISSUES	O	3_Yellow_Days
.	O	O
THE	O	O
PRESENCE	O	O
OF	O	O
LAYERED	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
FLUID	3_Yellow_Days	3_Yellow_Days
CAN	3_Yellow_Days	3_Yellow_Days
NOT	3_Yellow_Days	3_Yellow_Days
BE	3_Yellow_Days	3_Yellow_Days
EXCLUDED	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
LEFT	O	3_Yellow_Days
LUNG	O	3_Yellow_Days
REMAINS	O	3_Yellow_Days
CLEAR	O	O
AND	O	O
THE	O	O
HEART	O	O
SIZE	O	O
NORMAL	O	O
.	O	O
REMOVAL	O	O
OF	O	O
RIGHT	O	O
CHEST	O	O
TUBE	O	O
WITHOUT	O	O
EVIDENCE	O	O
OF	O	O
COMPLICATION	O	O
.	O	O
SLIGHT	3_Yellow_Days	1_Red_Minutes
DIFFUSE	3_Yellow_Days	1_Red_Minutes
INCREASE	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
DENSITY	3_Yellow_Days	1_Red_Minutes
OVER	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
HEMITHORAX	3_Yellow_Days	3_Yellow_Days
RELATIVE	O	3_Yellow_Days
TO	O	3_Yellow_Days
THE	O	3_Yellow_Days
LEFT	O	3_Yellow_Days
,	O	3_Yellow_Days
POSSIBLY	O	3_Yellow_Days
DUE	O	3_Yellow_Days
TO	O	O
ASYMMETRY	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
SOFT	3_Yellow_Days	3_Yellow_Days
TISSUES	3_Yellow_Days	3_Yellow_Days
ALTHOUGH	O	3_Yellow_Days
THE	O	3_Yellow_Days
PRESENCE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
LAYERED	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
FLUID	3_Yellow_Days	3_Yellow_Days
CAN	3_Yellow_Days	3_Yellow_Days
NOT	3_Yellow_Days	3_Yellow_Days
BE	3_Yellow_Days	3_Yellow_Days
EXCLUDED	3_Yellow_Days	3_Yellow_Days
.	O	O
MCW	O	O
1834029	O	O
ANEURYSM	O	O
PROTOCOL	O	O
CT	O	O
ANGIO	O	O
CHEST	O	O
,	O	O
CT	O	O
ANGIO	O	O
ABDOMEN	O	O
&	O	O
CT	O	O
ANGIO	O	O
PELVIS	O	O
-LRB-	O	O
#	O	O
825B-C-D	O	O
-RRB-	O	O
EXAMINATION	O	O
IS	O	O
PERFORMED	O	O
USING	O	O
HELICAL	O	O
ACQUISITION	O	O
WITH	O	O
0.625	O	O
MM	O	O
DETECTOR	O	O
COLLIMATION	O	O
.	O	O
RETROSPECTIVE	O	O
EKG	O	O
GATING	O	O
WAS	O	O
UTILIZED	O	O
FOR	O	O
STUDY	O	O
OF	O	O
THE	O	O
THORACIC	O	O
AORTA	O	O
AND	O	O
NON-GATED	O	O
EXAMINATION	O	O
FOR	O	O
STUDY	O	O
OF	O	O
THE	O	O
AORTOILIAC	O	O
VESSELS	O	O
.	O	O
COMPARISON	O	O
IS	O	O
MADE	O	O
TO	O	O
A	O	O
RECENT	O	O
PULMONARY	O	O
EMBOLISM	O	O
CT	O	O
STUDY	O	O
OF	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
ATHEROSCLEROTIC	3_Yellow_Days	3_Yellow_Days
DISEASE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
THORACOABDOMINAL	3_Yellow_Days	3_Yellow_Days
AORTA	3_Yellow_Days	3_Yellow_Days
WITH	O	3_Yellow_Days
A	O	3_Yellow_Days
SMALL	1_Red_Minutes	3_Yellow_Days
SACCULAR	1_Red_Minutes	3_Yellow_Days
ANEURYSM	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
INFRARENAL	1_Red_Minutes	O
AORTA	1_Red_Minutes	O
,	1_Red_Minutes	O
AP	1_Red_Minutes	1_Red_Minutes
DIAMETER	1_Red_Minutes	1_Red_Minutes
4	1_Red_Minutes	O
CM	1_Red_Minutes	O
AND	1_Red_Minutes	O
TRANSVERSE	1_Red_Minutes	O
DIAMETER	1_Red_Minutes	O
ABOUT	1_Red_Minutes	O
6	1_Red_Minutes	O
CM	1_Red_Minutes	O
.	O	O
THIS	O	O
SACCULAR	1_Red_Minutes	O
ANEURYSM	1_Red_Minutes	O
CONTAINS	1_Red_Minutes	O
A	1_Red_Minutes	O
PROMINENT	1_Red_Minutes	O
LAYER	1_Red_Minutes	O
OF	1_Red_Minutes	O
LINING	1_Red_Minutes	O
THROMBUS	1_Red_Minutes	O
ON	1_Red_Minutes	O
ITS	1_Red_Minutes	O
LEFT	1_Red_Minutes	O
LATERAL	1_Red_Minutes	O
MARGIN	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
AORTIC	O	O
DISSECTION	O	O
.	O	O
NO	O	O
OTHER	O	O
FOCAL	O	O
ANEURYSM	O	O
IS	O	O
SEEN	O	O
.	O	O
THERE	O	O
IS	O	O
PROMINENT	3_Yellow_Days	O
ATHEROSCLEROTIC	3_Yellow_Days	O
DISEASE	3_Yellow_Days	O
INVOLVING	3_Yellow_Days	O
THE	3_Yellow_Days	O
ORIFICES	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
INNOMINATE	3_Yellow_Days	O
,	3_Yellow_Days	O
LEFT	3_Yellow_Days	1_Red_Minutes
COMMON	3_Yellow_Days	1_Red_Minutes
CAROTID	3_Yellow_Days	1_Red_Minutes
AND	3_Yellow_Days	3_Yellow_Days
LEFT	3_Yellow_Days	3_Yellow_Days
SUBCLAVIAN	3_Yellow_Days	3_Yellow_Days
ARTERIES	3_Yellow_Days	3_Yellow_Days
WITH	O	O
STENOSIS	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
BOTH	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	O
LEFT	1_Red_Minutes	1_Red_Minutes
COMMON	1_Red_Minutes	1_Red_Minutes
CAROTID	1_Red_Minutes	1_Red_Minutes
AND	1_Red_Minutes	3_Yellow_Days
LEFT	1_Red_Minutes	3_Yellow_Days
SUBCLAVIAN	1_Red_Minutes	3_Yellow_Days
ARTERIES	1_Red_Minutes	3_Yellow_Days
.	O	O
AP	O	3_Yellow_Days
DIAMETER	O	3_Yellow_Days
OF	O	O
THE	O	O
MID	O	O
ASCENDING	O	O
AORTA	O	O
IS	O	O
37	O	3_Yellow_Days
MM	O	3_Yellow_Days
AND	O	O
OF	O	O
THE	O	O
MID	O	O
DESCENDING	O	O
AORTA	O	O
26	O	O
MM	O	O
.	O	O
NORMAL	O	O
DIMENSIONS	O	O
OF	O	O
THE	O	O
SUPRARENAL	O	O
AND	O	O
JUXTARENAL	O	O
ABDOMINAL	O	O
AORTA	O	O
.	O	O
THERE	O	O
IS	O	O
PROMINENT	3_Yellow_Days	O
IRREGULAR	3_Yellow_Days	O
ATHEROTHROMBOSIS	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
SUPRARENAL	3_Yellow_Days	O
AND	3_Yellow_Days	O
INFRARENAL	3_Yellow_Days	O
AORTA	3_Yellow_Days	O
.	O	O
THE	O	O
CELIAC	O	O
,	O	O
SUPERIOR	O	O
MESENTERIC	O	O
AND	O	O
INFERIOR	O	O
MESENTERIC	O	O
ARTERIES	O	O
ARE	O	O
PATENT	O	O
.	O	O
PROMINENT	3_Yellow_Days	O
ATHEROSCLEROTIC	3_Yellow_Days	O
CALCIFICATION	3_Yellow_Days	O
AT	3_Yellow_Days	O
THE	3_Yellow_Days	O
OSTIUM	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
SUPERIOR	3_Yellow_Days	3_Yellow_Days
MESENTERIC	3_Yellow_Days	3_Yellow_Days
ARTERY	3_Yellow_Days	3_Yellow_Days
BUT	3_Yellow_Days	3_Yellow_Days
WITHOUT	3_Yellow_Days	O
SIGNIFICANT	3_Yellow_Days	O
STENOSIS	3_Yellow_Days	O
.	O	O
SINGLE	3_Yellow_Days	3_Yellow_Days
RENAL	3_Yellow_Days	3_Yellow_Days
ARTERIES	3_Yellow_Days	3_Yellow_Days
TO	3_Yellow_Days	O
EACH	3_Yellow_Days	O
KIDNEY	3_Yellow_Days	O
WITH	3_Yellow_Days	O
PROMINENT	3_Yellow_Days	O
LINING	3_Yellow_Days	O
ATHEROTHROMBOSIS	3_Yellow_Days	O
BUT	O	O
WITHOUT	O	O
SIGNIFICANT	O	O
STENOSIS	O	O
.	O	O
THERE	O	O
IS	O	O
EXTENSIVE	3_Yellow_Days	O
ATHEROSCLEROTIC	3_Yellow_Days	O
DISEASE	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
BILATERAL	3_Yellow_Days	O
COMMON	3_Yellow_Days	O
ILIAC	3_Yellow_Days	O
,	3_Yellow_Days	O
EXTERNAL	3_Yellow_Days	O
ILIAC	3_Yellow_Days	O
,	3_Yellow_Days	O
COMMON	3_Yellow_Days	O
FEMORAL	3_Yellow_Days	O
AND	3_Yellow_Days	O
PROXIMAL	3_Yellow_Days	O
SUPERFICIAL	3_Yellow_Days	O
AND	3_Yellow_Days	O
PROFUNDA	3_Yellow_Days	O
FEMORAL	3_Yellow_Days	O
ARTERIES	3_Yellow_Days	O
.	O	O
NO	O	O
SIGNIFICANT	O	O
STENOSIS	O	O
.	O	O
BOTH	O	O
HYPOGASTRIC	O	O
ARTERIES	O	O
ARE	O	O
PATENT	O	O
.	O	O
AS	O	O
PREVIOUSLY	O	O
,	O	O
THERE	O	O
IS	O	O
EXTENSIVE	3_Yellow_Days	3_Yellow_Days
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
,	O	O
MOST	O	3_Yellow_Days
MARKED	O	3_Yellow_Days
IN	O	3_Yellow_Days
THE	O	3_Yellow_Days
MID	O	3_Yellow_Days
AND	O	3_Yellow_Days
UPPER	O	3_Yellow_Days
LUNG	O	3_Yellow_Days
FIELDS	O	3_Yellow_Days
.	O	O
MULTIFOCAL	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
ARE	3_Yellow_Days	3_Yellow_Days
UNCHANGED	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
LARGEST	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULE	3_Yellow_Days	3_Yellow_Days
IS	O	O
NOTED	O	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
MEDIAL	3_Yellow_Days	O
ASPECT	3_Yellow_Days	1_Red_Minutes
LEFT	3_Yellow_Days	1_Red_Minutes
LOWER	3_Yellow_Days	1_Red_Minutes
LOBE	3_Yellow_Days	1_Red_Minutes
APPROXIMATELY	O	1_Red_Minutes
6	1_Red_Minutes	1_Red_Minutes
MM	1_Red_Minutes	1_Red_Minutes
IN	1_Red_Minutes	1_Red_Minutes
DIAMETER	1_Red_Minutes	1_Red_Minutes
WITH	1_Red_Minutes	1_Red_Minutes
SPICULATED	1_Red_Minutes	1_Red_Minutes
MARGIN	1_Red_Minutes	1_Red_Minutes
.	O	O
IT	3_Yellow_Days	O
IS	3_Yellow_Days	O
UNCHANGED	3_Yellow_Days	O
IN	O	O
COMPARISON	O	O
TO	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
OPACIFICATION	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
PULMONARY	3_Yellow_Days	O
ARTERIES	3_Yellow_Days	O
IS	3_Yellow_Days	O
SUBOPTIMAL	3_Yellow_Days	3_Yellow_Days
.	O	O
HOWEVER	O	O
,	O	O
NO	O	O
PULMONARY	O	O
EMBOLI	O	O
ARE	O	O
SEEN	O	O
.	O	O
ARTERIAL	O	O
PHASE	O	O
IMAGES	O	O
OF	O	O
THE	O	O
LIVER	O	O
,	O	O
SPLEEN	O	O
,	O	O
PANCREAS	O	O
AND	O	O
ADRENAL	O	O
GLANDS	O	O
APPEAR	O	O
NORMAL	O	O
.	O	O
RIGHT	O	O
AND	O	O
LEFT	O	O
KIDNEYS	O	O
APPEAR	O	O
MORPHOLOGICALLY	O	O
NORMAL	O	O
.	O	O
NORMAL	O	O
APPEARANCE	O	O
OF	O	O
THE	O	O
BOWEL	O	O
AND	O	O
MESENTERY	O	O
IN	O	O
THE	O	O
ABDOMEN	O	O
AND	O	O
PELVIS	O	O
.	O	O
EXTENSIVE	3_Yellow_Days	3_Yellow_Days
DEGENERATIVE	3_Yellow_Days	3_Yellow_Days
JOINT	3_Yellow_Days	3_Yellow_Days
DISEASE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
THORACOLUMBAR	3_Yellow_Days	3_Yellow_Days
SPINE	3_Yellow_Days	3_Yellow_Days
.	O	O
NOTE	O	O
IS	O	O
MADE	O	O
OF	O	O
LEFT	3_Yellow_Days	O
VENTRICULAR	3_Yellow_Days	1_Red_Minutes
HYPERTROPHY	3_Yellow_Days	1_Red_Minutes
.	O	O
THERE	O	O
IS	O	O
A	O	O
TRICUSPID	3_Yellow_Days	O
AORTIC	3_Yellow_Days	O
VALVE	3_Yellow_Days	O
WITH	3_Yellow_Days	O
PROMINENT	3_Yellow_Days	O
CALCIFICATION	3_Yellow_Days	O
AT	O	O
THE	O	O
VALVE	O	O
COMMISSURES	O	O
.	O	O
1	O	O
.	O	O
ADVANCED	3_Yellow_Days	3_Yellow_Days
ATHEROSCLEROTIC	3_Yellow_Days	O
DISEASE	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
THORACOABDOMINAL	3_Yellow_Days	O
AORTA	3_Yellow_Days	O
.	O	O
FOCAL	1_Red_Minutes	O
SACCULAR	1_Red_Minutes	O
INFRARENAL	1_Red_Minutes	O
ANEURYSM	1_Red_Minutes	O
WITH	O	O
PROMINENT	O	3_Yellow_Days
LINING	O	3_Yellow_Days
MURAL	O	3_Yellow_Days
THROMBUS	O	3_Yellow_Days
.	O	O
2	O	O
.	O	O
LEFT	3_Yellow_Days	3_Yellow_Days
VENTICULAR	3_Yellow_Days	3_Yellow_Days
HYPERTROPHY	3_Yellow_Days	3_Yellow_Days
.	O	O
3	O	O
.	O	O
NO	O	O
AORTIC	O	O
DISSECTION	O	O
.	O	O
4	O	O
.	O	O
STENOSED	1_Red_Minutes	O
ORIGINS	1_Red_Minutes	O
OF	1_Red_Minutes	O
LEFT	1_Red_Minutes	1_Red_Minutes
COMMON	1_Red_Minutes	1_Red_Minutes
CAROTID	1_Red_Minutes	1_Red_Minutes
AND	1_Red_Minutes	1_Red_Minutes
LEFT	1_Red_Minutes	3_Yellow_Days
SUBCLAVIAN	1_Red_Minutes	3_Yellow_Days
ARTERIES	1_Red_Minutes	3_Yellow_Days
.	O	O
5	O	O
.	O	O
PATENT	O	O
ABDOMINAL	O	O
VISCERAL	O	O
BRANCH	O	O
VESSELS	O	O
.	O	O
INFERIOR	O	O
MESENTERIC	O	O
ARTERY	O	O
PATENT	O	O
AND	O	O
ARISING	O	O
AT	O	1_Red_Minutes
DISTAL	O	1_Red_Minutes
MARGIN	O	1_Red_Minutes
OF	O	1_Red_Minutes
SACCULAR	O	1_Red_Minutes
ANEURYSM	O	1_Red_Minutes
.	O	O
6	O	O
.	O	O
NORMAL	O	O
PATENCY	O	O
OF	O	O
ATHEROSCLEROTIC	O	O
ILIAC	O	O
OUTFLOW	O	O
VASCULATURE	O	O
.	O	O
7	O	O
.	O	O
EXTENSIVE	3_Yellow_Days	3_Yellow_Days
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
MULTIPLE	3_Yellow_Days	O
SMALL	3_Yellow_Days	O
PULMONARY	3_Yellow_Days	O
NODULES	3_Yellow_Days	O
,	3_Yellow_Days	O
UNCHANGED	3_Yellow_Days	O
.	O	O
MCW	O	O
1820463	O	O
PE	O	O
PROTOCOL	O	O
CT	O	O
THORAX	O	O
AND	O	O
CT	O	O
PELVIS	O	O
-	O	O
PE	O	O
PROTOCOL	O	O
-LRB-	O	O
#	O	O
569B-C	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
WAS	O	O
PERFORMED	O	O
FOLLOWING	O	O
THE	O	O
ADMINISTRATION	O	O
OF	O	O
145	O	O
ML	O	O
OF	O	O
OMNIPAQUE	O	O
350	O	O
.	O	O
1.25	O	O
MM	O	O
AXIAL	O	O
IMAGES	O	O
AND	O	O
1.3	O	O
MM	O	O
CORONAL	O	O
SAGITTAL	O	O
IMAGES	O	O
WERE	O	O
REVIEWED	O	O
.	O	O
DELAYED	O	O
NON	O	O
-	O	O
CONTIGUOUS	O	O
AXIAL	O	O
IMAGES	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
PORTION	O	O
OF	O	O
THE	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
LATER	O	O
ACQUIRED	O	O
.	O	O
COMPARISON	O	O
:	O	O
CT	O	O
CHEST	O	O
WITHOUT	O	O
CONTRAST	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
THE	O	O
OPACIFICATION	O	O
OF	O	O
THE	O	O
PULMONARY	O	O
VESSELS	O	O
IS	O	O
ADEQUATE	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
THE	O	O
HEART	3_Yellow_Days	3_Yellow_Days
REMAINS	3_Yellow_Days	3_Yellow_Days
DIFFUSELY	3_Yellow_Days	3_Yellow_Days
ENLARGED	3_Yellow_Days	3_Yellow_Days
,	O	3_Yellow_Days
PARTICULARLY	O	3_Yellow_Days
THE	O	1_Red_Minutes
LEFT	O	1_Red_Minutes
ATRIUM	O	1_Red_Minutes
.	O	O
THE	O	O
MAIN	O	O
PULMONARY	O	O
ARTERY	O	O
IS	O	O
NORMAL	O	O
IN	O	O
CALIBER	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
CORONARY	3_Yellow_Days	3_Yellow_Days
ARTERY	3_Yellow_Days	3_Yellow_Days
CALCIFIED	3_Yellow_Days	3_Yellow_Days
ATHEROMATOSIS	3_Yellow_Days	3_Yellow_Days
.	O	O
NO	O	O
PERICARDIAL	O	O
EFFUSION	O	O
IS	O	O
SEEN	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
MASS	O	O
OR	O	O
LYMPHADENOPATHY	O	O
IN	O	O
THE	O	O
MEDIASTINUM	O	O
OR	O	O
PULMONARY	O	O
HILA	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
TRACHEOSTOMY	O	O
TUBE	O	O
IN	O	O
PLACE	O	O
.	O	O
THE	O	O
PROMINENCE	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
HILAR	1_Red_Minutes	1_Red_Minutes
STRUCTURES	1_Red_Minutes	1_Red_Minutes
DUE	1_Red_Minutes	1_Red_Minutes
TO	1_Red_Minutes	O
PROMINENT	1_Red_Minutes	3_Yellow_Days
PULMONARY	1_Red_Minutes	3_Yellow_Days
ARTERIAL	1_Red_Minutes	3_Yellow_Days
AND	1_Red_Minutes	3_Yellow_Days
VENOUS	1_Red_Minutes	3_Yellow_Days
SYSTEM	1_Red_Minutes	3_Yellow_Days
.	O	O
POST	1_Red_Minutes	O
ANASTOMOTIC	1_Red_Minutes	O
DILATATION	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
PULMONARY	1_Red_Minutes	1_Red_Minutes
ARTERY	1_Red_Minutes	1_Red_Minutes
SUGGESTS	1_Red_Minutes	1_Red_Minutes
SOME	1_Red_Minutes	1_Red_Minutes
DEGREE	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
STENOSIS	1_Red_Minutes	1_Red_Minutes
AT	1_Red_Minutes	O
THE	1_Red_Minutes	O
LEVEL	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
ANASTOMOSIS	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
,	O	O
HOWEVER	O	O
,	O	O
NO	O	O
SIGNS	O	O
OF	O	O
PSEUDOANEURYSM	O	O
,	O	O
EXTRAVASATION	O	O
OR	O	O
HEMATOMA	O	O
AT	O	O
THIS	O	O
LEVEL	O	O
.	O	O
THERE	O	O
IS	O	O
A	1_Red_Minutes	O
PERSISTENT	1_Red_Minutes	3_Yellow_Days
MODERATE	1_Red_Minutes	3_Yellow_Days
LEFT	1_Red_Minutes	3_Yellow_Days
PLEURAL	1_Red_Minutes	3_Yellow_Days
EFFUSION	1_Red_Minutes	3_Yellow_Days
,	O	O
LEFT	3_Yellow_Days	1_Red_Minutes
LOWER	3_Yellow_Days	1_Red_Minutes
LOBE	3_Yellow_Days	1_Red_Minutes
ATELECTASIS	3_Yellow_Days	1_Red_Minutes
AND	O	1_Red_Minutes
MARKED	1_Red_Minutes	1_Red_Minutes
CENTRILOBULAR	1_Red_Minutes	3_Yellow_Days
EMPHYSEMA	1_Red_Minutes	3_Yellow_Days
IN	O	3_Yellow_Days
THE	O	3_Yellow_Days
AERATED	O	3_Yellow_Days
PORTION	O	3_Yellow_Days
OF	O	3_Yellow_Days
THE	O	3_Yellow_Days
LEFT	O	3_Yellow_Days
LUNG	O	3_Yellow_Days
.	O	O
PERSISTENT	3_Yellow_Days	O
PARTIAL	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
LOWER	3_Yellow_Days	O
LOBE	3_Yellow_Days	O
,	O	O
AND	O	O
PERSISTENT	3_Yellow_Days	O
GROUND	3_Yellow_Days	O
GLASS	3_Yellow_Days	O
OPACITIES	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
UPPER	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
.	O	O
THERE	O	O
HAS	O	O
BEEN	O	O
DECREASE	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
AMOUNT	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
ASCITES	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
PERIHEPATIC	3_Yellow_Days	1_Red_Minutes
REGION	3_Yellow_Days	1_Red_Minutes
.	O	O
THERE	O	O
IS	O	O
AN	O	O
ACUTE	1_Red_Minutes	O
DVT	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
COMMON	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
SLIGHTLY	O	O
EXTENDING	O	O
INTO	O	O
THE	O	O
SUPERFICIAL	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
SIDE	O	O
AND	O	O
ALSO	O	O
IN	O	O
THE	O	O
PROFUNDA	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
LEFT.THERE	O	O
IS	O	O
MILD	3_Yellow_Days	3_Yellow_Days
SUBCUTANEOUS	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
BOTH	3_Yellow_Days	3_Yellow_Days
LEGS	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
UNCHANGED	O	O
DIFFUSE	O	O
OSTEOPENIA	O	O
,	O	O
CHANGES	O	O
POST-RIGHT	O	O
THORACOTOMY	O	O
AND	O	O
MULTIPLE	O	O
OLD	O	O
RIB	O	O
FRACTURES	O	O
ON	O	O
BOTH	O	O
SIDES	O	O
OF	O	O
THE	O	O
THORACIC	O	O
CAGE	O	O
.	O	O
1	O	O
.	O	O
NEGATIVE	O	O
STUDY	O	O
FOR	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
SIGNS	O	O
OF	O	O
ACUTE	1_Red_Minutes	O
DEEP	1_Red_Minutes	O
VENOUS	1_Red_Minutes	O
THROMBOSIS	1_Red_Minutes	O
INVOLVING	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	1_Red_Minutes
COMMON/SUPERFICIAL	1_Red_Minutes	1_Red_Minutes
FEMORAL	1_Red_Minutes	1_Red_Minutes
VEIN	1_Red_Minutes	1_Red_Minutes
ON	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
AND	O	1_Red_Minutes
PROFUNDA	1_Red_Minutes	1_Red_Minutes
FEMORAL	1_Red_Minutes	1_Red_Minutes
VEIN	1_Red_Minutes	1_Red_Minutes
ON	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
LEFT	1_Red_Minutes	1_Red_Minutes
.	O	O
2	O	O
.	O	O
PROMINENT	O	3_Yellow_Days
RIGHT	O	3_Yellow_Days
HILUM	O	3_Yellow_Days
SECONDARY	O	3_Yellow_Days
TO	O	3_Yellow_Days
PROMINENCE	O	3_Yellow_Days
OF	O	3_Yellow_Days
THE	O	3_Yellow_Days
VASCULAR	O	3_Yellow_Days
STRUCTURES	O	3_Yellow_Days
INCLUDING	O	O
ARTERIES	O	3_Yellow_Days
AND	O	O
VEINS	O	O
.	O	O
THE	O	O
POSSIBILITY	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	3_Yellow_Days
MILD	1_Red_Minutes	3_Yellow_Days
STENOSIS	1_Red_Minutes	3_Yellow_Days
AT	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
ANASTOMOSIS	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
PULMONARY	1_Red_Minutes	1_Red_Minutes
ARTERY	1_Red_Minutes	1_Red_Minutes
IS	O	O
RAISED	O	O
.	O	O
3	O	O
.	O	O
PERSISTENT	3_Yellow_Days	3_Yellow_Days
DIFFUSE	3_Yellow_Days	3_Yellow_Days
HAZINESS	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
LUNG	3_Yellow_Days	3_Yellow_Days
,	O	O
WHICH	O	O
COULD	O	1_Red_Minutes
BE	O	O
RELATED	O	O
TO	O	O
CHRONIC	3_Yellow_Days	3_Yellow_Days
ATELECTASIS	3_Yellow_Days	3_Yellow_Days
.	O	O
4	O	O
.	O	O
PERSISTENT	O	O
BIBASILAR	3_Yellow_Days	O
PARTIAL	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
,	O	O
ESPECIALLY	O	O
ON	O	O
THE	O	O
LEFT	O	O
SIDE	O	O
,	O	O
5	O	O
.	O	O
UNCHANGED	O	O
LEFT	3_Yellow_Days	O
PLEURAL	3_Yellow_Days	O
EFFUSION	3_Yellow_Days	O
,	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
AND	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
NATIVE	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
.	O	O
6	O	O
.	O	O
DECREASED	3_Yellow_Days	O
ASCITES	3_Yellow_Days	O
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
446524707	O	O
260278	O	O
IMGCTTW	O	O
CT	O	O
THORAX	O	O
W	O	O
CONTRAST	O	O
IMPRESSION	O	O
:	O	O
CT	O	O
CHEST	O	O
WITH	O	O
CONTRAST	O	O
:	O	O
10/8/2014	O	O
12:05	O	O
PM	O	O
CLINICAL	O	O
HISTORY	O	O
:	O	O
71	O	O
years	O	O
of	O	O
age	O	O
,	O	O
Female	O	O
,	O	O
71	O	O
year	O	O
old	O	O
female	O	O
with	O	O
1	O	O
.	O	O
Status	O	O
post	O	O
interval	O	O
right	O	O
lower	O	O
lobectomy	O	O
with	O	O
a	O	O
new	3_Yellow_Days	O
small	3_Yellow_Days	O
right	3_Yellow_Days	O
pleural	3_Yellow_Days	O
effusion	3_Yellow_Days	O
,	3_Yellow_Days	O
likely	3_Yellow_Days	O
postsurgical	3_Yellow_Days	O
.	O	O
No	O	O
definite	O	O
CT	O	O
evidence	O	O
for	O	O
stage	O	O
IIA	O	O
NSCLC	O	O
s/p	O	O
RLL	O	O
lobectomy	O	O
and	O	O
3	O	O
cycles	O	O
of	O	O
adjuvant	O	O
chemotherapy	O	O
needing	O	O
imaging	O	O
.	O	O
.	O	O
tumor	O	O
recurrence	O	O
.	O	O
No	O	O
thoracic	O	O
lymphadenopathy	O	O
by	O	O
CT	O	O
size	O	O
criteria	O	O
.	O	O
2	O	O
.	O	O
New	3_Yellow_Days	3_Yellow_Days
3	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
noncalcified	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
identified	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
minor	3_Yellow_Days	O
COMPARISON	O	O
:	O	O
CT	O	O
scan	O	O
dated	O	O
3/14/2014	O	O
.	O	O
PET/CT	O	O
scan	O	O
dated	O	O
3/24/2014	O	O
.	O	O
fissure	O	O
,	O	O
which	O	O
may	O	O
be	O	O
postsurgical	O	O
.	O	O
Additional	O	O
scattered	3_Yellow_Days	3_Yellow_Days
sub-4	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
noncalcified	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
are	3_Yellow_Days	O
all	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
size	3_Yellow_Days	O
as	3_Yellow_Days	O
compared	3_Yellow_Days	O
PROCEDURE	O	O
COMMENTS	O	O
:	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
performed	O	O
following	O	O
administration	O	O
of	O	O
75	O	O
mL	O	O
of	O	O
IV	O	O
contrast	O	O
.	O	O
with	O	O
the	O	O
prior	O	O
study	O	O
.	O	O
Attention	3_Yellow_Days	O
at	3_Yellow_Days	O
follow-up	3_Yellow_Days	O
is	3_Yellow_Days	O
recommended	3_Yellow_Days	O
.	O	O
3	O	O
.	O	O
Stable	3_Yellow_Days	3_Yellow_Days
1.7	3_Yellow_Days	3_Yellow_Days
cm	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
with	3_Yellow_Days	O
a	3_Yellow_Days	O
central	3_Yellow_Days	O
coarse	3_Yellow_Days	O
calcification	3_Yellow_Days	O
within	3_Yellow_Days	O
Dose	O	O
information	O	O
:	O	O
Based	O	O
on	O	O
a	O	O
32	O	O
cm	O	O
phantom	O	O
,	O	O
the	O	O
estimated	O	O
radiation	O	O
dose	O	O
-LRB-	O	O
CTDIvol	O	O
-LSB-	O	O
mGy	O	O
-RSB-	O	O
-RRB-	O	O
for	O	O
each	O	O
series	O	O
in	O	O
this	O	O
exam	O	O
is	O	O
12.98	O	O
.	O	O
The	O	O
the	O	O
left	O	O
lower	O	O
lobe	O	O
,	O	O
which	O	O
was	O	O
not	O	O
hypermetabolic	O	O
on	O	O
the	O	O
prior	O	O
PET/CT	O	O
of	O	O
3/24/2014	O	O
and	O	O
may	O	O
represent	O	O
a	O	O
granuloma	O	O
.	O	O
estimated	O	O
cumulative	O	O
dose	O	O
-LRB-	O	O
DLP	O	O
-LSB-	O	O
mGy-cm	O	O
-RSB-	O	O
-RRB-	O	O
is	O	O
467	O	O
.	O	O
I	O	O
have	O	O
personally	O	O
reviewed	O	O
the	O	O
images	O	O
for	O	O
this	O	O
examination	O	O
and	O	O
agreed	O	O
with	O	O
the	O	O
report	O	O
transcribed	O	O
above	O	O
.	O	O
FINDINGS	O	O
:	O	O
Medical	O	O
devices	O	O
:	O	O
None	O	O
.	O	O
Thyroid	O	O
:	O	O
Normal	O	O
.	O	O
Lymph	O	O
nodes	O	O
:	O	O
No	O	O
supraclavicular	O	O
,	O	O
axillary	O	O
,	O	O
mediastinal	O	O
,	O	O
or	O	O
hilar	O	O
lymphadenopathy	O	O
.	O	O
Vasculature	O	O
:	O	O
Aorta	O	O
and	O	O
main	O	3_Yellow_Days
pulmonary	O	3_Yellow_Days
artery	O	3_Yellow_Days
diameters	O	3_Yellow_Days
are	O	O
within	O	O
normal	O	O
range	O	O
.	O	O
Scattered	3_Yellow_Days	3_Yellow_Days
atherosclerotic	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
are	3_Yellow_Days	3_Yellow_Days
identified	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
thoracoabdominal	3_Yellow_Days	O
aorta	3_Yellow_Days	O
.	O	O
Heart	O	O
:	O	O
No	O	O
pericardial	O	O
effusion	O	O
.	O	O
Other	O	O
mediastinal	O	O
structures	O	O
:	O	O
Small	O	O
hiatal	O	O
hernia	O	O
.	O	O
Lung	O	O
parenchyma	O	O
and	O	O
pleura	O	O
:	O	O
Status	O	O
post	O	O
interval	O	O
right	O	O
lower	O	O
lobectomy	O	O
with	O	O
a	O	O
new	3_Yellow_Days	O
small	3_Yellow_Days	O
right	3_Yellow_Days	O
pleural	3_Yellow_Days	O
effusion	3_Yellow_Days	O
,	3_Yellow_Days	O
likely	3_Yellow_Days	O
postsurgical	3_Yellow_Days	O
.	O	O
No	O	O
left	O	O
pleural	O	O
effusion	O	O
.	O	O
There	O	O
is	O	O
a	O	O
stable	3_Yellow_Days	3_Yellow_Days
1.7	3_Yellow_Days	3_Yellow_Days
cm	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
with	3_Yellow_Days	3_Yellow_Days
a	3_Yellow_Days	3_Yellow_Days
central	3_Yellow_Days	3_Yellow_Days
coarse	3_Yellow_Days	3_Yellow_Days
calcification	3_Yellow_Days	3_Yellow_Days
within	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
left	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
-LRB-	O	O
series	O	O
2	O	O
,	O	O
image	O	O
50	O	O
-RRB-	O	O
.	O	O
There	O	O
is	O	O
a	O	O
new	3_Yellow_Days	3_Yellow_Days
3	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
noncalcified	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
identified	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	3_Yellow_Days
minor	3_Yellow_Days	3_Yellow_Days
fissure	3_Yellow_Days	3_Yellow_Days
-LRB-	O	O
series	O	O
3	O	O
,	O	O
image	O	O
165	O	O
-RRB-	O	O
.	O	O
There	O	O
are	O	O
additional	3_Yellow_Days	O
scattered	3_Yellow_Days	3_Yellow_Days
sub-4	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
noncalcified	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
as	O	O
indicated	O	O
on	O	O
series	O	O
3	O	O
on	O	O
PACS	O	O
,	O	O
which	O	O
are	O	O
all	3_Yellow_Days	O
stable	3_Yellow_Days	O
in	O	O
size	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
prior	O	O
study	O	O
.	O	O
Airways	O	O
:	O	O
Patent	O	O
central	O	O
airways	O	O
.	O	O
Chest	O	O
wall	O	O
and	O	O
spine	O	O
:	O	O
No	O	O
suspicious	O	O
osseous	O	O
lesion	O	O
.	O	O
Upper	O	O
abdomen	O	O
:	O	O
Normal	O	O
.	O	O
054.9	O	O
162.5	O	O
162.9	O	O
173.51	O	O
203.00	O	O
211.3	O	O
216.9	O	O
272.8	O	O
273.1	O	O
276.1	O	O

